FeesSafety
Pluang+

Solana's tokenized-equity supply hits $1.28B, adding $670M in a week, with $7.1B traded in Q3.

Protocol Fundamentals
10 Nov 2026, 14:07 WIB
Tokenpost
View Source
Bullish
Solana's tokenized-equity supply hits $1.28B, adding $670M in a week, with $7.1B traded in Q3.

Solana's tokenized-equity supply reached a new record of $1.28 billion, with over $670 million added in just one week. This figure represents the total value of tokenized equities outstanding on the platform, not the trading volume. In the third quarter, decentralized exchange (DEX) trading of tokenized equities on Solana totaled $7.1 billion. The supply figure and trading volume measure different aspects: the supply shows assets outstanding at a point in time, while the trading volume reflects activity over the quarter.

Solana's tokenized-equity supply hitting a record $1.28 billion provides context for the broader crypto market. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Nov 10, 2026 18:41 WIB: out of 50 major cryptocurrencies, 31 rose and 18 fell today. Notably, Nano (XNO) gained 3.23% to Rp5,785 with 100% buy orders and a typical hold time of 87 days, Avalanche (AVAX) rose 3.13% to Rp150,211 with 59% sell orders, and Terra Classic (LUNC) increased 2.22% to Rp0.721 with 79% buy orders and a 197-day hold time.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
34 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
34 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
34 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
34 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App